One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study II

International Journal of Cardiology

Volumn 122, Issue 1, 2007, Pages 52-55

  Rasoul, Saman ^a   Ottervanger, Jan Paul ^a   Timmer, Jorik R ^a   Svilaas, Tone ^b   Henriques, Jose P S ^c   Dambrink, Jan Henk E ^a   van der Horst, Iwan C C ^b   Zijlstra, Felix ^b  

^a Isala Klinieken ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Glucose insulin potassium; Long term outcome; STEMI

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; POTASSIUM; STATINE DERIVATIVE; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART PERFUSION; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; INSULIN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POTASSIUM; RECURRENCE; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 34848814475     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.037     Document Type: Article

References (16)

1. Fath-Ordoubadi F., and Beatt K.J. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 96 (1997) 1152-1156
2. Malmberg K., Ryden L., Efendic S., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
3. Van der Horst I.C., Zijlstra F., van't Hof A.W.J., et al. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol 42 (2003) 784-791
4. Timmer J.R., Svilaas T., Ottervanger J.P., et al. Glucose-insulin-potassium infusion in patients with acute myocardial infarction without signs of heart failure: the glucose-insulin-potassium-study II. J Am Coll Cardiol 47 (2006) 1730-1731 [Letter]
5. Mehta S.R., Yusuf S., Diaz R., Zhu J., et al. CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomised controlled trial. JAMA 293 (2005) 437-446
6. Malmberg K., Ryden L., Wedel H., et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661
7. van der Horst I.C., Timmer J.R., Ottervanger J.P., et al. GIPS Investigators. Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2). Am Heart J 149 (2005) 585-591
8. Diaz R., Paolasso E.A., Piegas L.S., et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 98 (1998) 2227-2234
9. Apstein C.S., and Opie L.H. A challenge to the metabolic approach to myocardial ischaemia. Eur Heart J 26 (2005) 956-959
10. Vanoverschelde J.L., Janier M.F., Bakke J.E., Marshall D.R., and Bergmann S.R. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Phys 267 (1994) H1785-H1794
11. Svensson A.M., McGuire D.K., Abrahamsson P., and Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 26 (2005) 1255-1261
12. McGuire D.K., Newby L.K., Bhapkar M.V., et al. Association of diabetes mellitus and glycaemic control strategies with clinical outcomes after acute coronary syndromes. Am Heart J 147 (2004) 246-252
13. Norhammar A.M., Ryden L., and Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 22 (1999) 1827-1831
14. Foo K., Cooper J., Deaner A., Knight C., et al. Single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 89 (2003) 512-516
15. Angiolillo D.J., Bernardo E., Ramirez C., et al. Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment. J Am Coll Cardiol 48 (2006) 298-304
16. Apstein C.S. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial. JAMA 293 (2005) 2596-2597